期刊文献+

髂内动脉化疗联合手术治疗膀胱癌 被引量:3

A study of internal iliac artery chemotherapy combined with operation for urinary bladder carcinoma
下载PDF
导出
摘要 目的:提高膀胱癌手术治疗的效果,尽可能保留有功能的膀胱,降低膀胱癌术后复发率。方法:对72例不同分期、分级的膀胱移行细胞癌患者随机分为两组,Ⅰ组40例行膀胱部分切除术或经尿道膀胱肿瘤电切术(TUR-Bt),术后加丝裂霉素膀胱灌注化疗;Ⅱ组32例术前行卡铂配伍阿霉素髂内动脉灌注化疗2次,后行膀胱部分切除术或经尿道膀胱肿瘤电切术,术后加丝裂霉素膀胱灌注化疗。均随诊2年,比较两组间治疗后膀胱癌复发率。结果:Ⅰ组,2年膀胱癌复发18例,复发率45%。Ⅱ组,2年膀胱癌复发6例,复发率18.75%。两组复发率比较差异有显著性(P<0.05)。Ⅱ组髂内动脉灌注化疗前后膀胱癌细胞分级(G)降低15例,分期(T)降低16例。结论:术前加用卡铂配伍阿霉素髂内动脉灌注化疗可使部分膀胱癌降级、降期,提高手术切除率,降低术后膀胱癌复发率,术前加用卡铂配伍阿霉素髂内动脉灌注化疗结合保留膀胱的手术是治疗膀胱癌的有效方法。 Objective: To elevate the surgery effect of bladder cancer and try to remain the bladder function as well as reduce recurrence. Methods: Seventy-two patients were divided into two groups randomly. The contrast group (40 cases) received partial cystectomy or TUR Bt and postoperately bladder infusion chemotherapy. The study group (32 cases) received twice intra-artery infusion chemotherapy preoperately and partial eystectomy or TUR Bt, and bladder infusion chemotherapy postoperately. Both the groups were followed up for two years, and the recurrence rates were compared. Results: Eighteen and 6 eases recurred in the contrast group (45%) and the study group (18.75%) respectively after two years followed up. There was a significant difference between the two groups. Conclusion: Intra-artery infusion chemotherapy preoperately can decrease the degree and grade of bladder cancer and increase the surgery chance as well as reduce recurrence. The method of intra-artery infusion chemotherapy preoperatety and bladder reserve operation is effective and useful for bladder cancer.
出处 《中国中西医结合影像学杂志》 2008年第6期434-436,共3页 Chinese Imaging Journal of Integrated Traditional and Western Medicine
关键词 膀胱肿瘤 新辅助化疗 手术 Bladder neoplasms Carcinoma Neoadjuvant chemotherapy Operation
  • 相关文献

参考文献10

  • 1王晓民,赵玉兰.膀胱移行细胞癌动脉化疗的临床,病理和超微结构观察[J].中华泌尿外科杂志,1991,12(4):270-272. 被引量:26
  • 2石梅海,蔡文清.经尿道电切加化疗治疗膀胱癌[J].中华泌尿外科杂志,1993,14(2):111-112. 被引量:8
  • 3张思孝,申鹏飞.浸润性膀胱癌放、化疗的近况[J].国外医学(泌尿系统分册),1992,12(3):99-102. 被引量:4
  • 4[5]Brantly TJ,David CE.Current management of invasive and metastatic transitional cell carcinoma of the bladder[J].J Urol,1993,149:957-962.
  • 5[6]Kubota Y,Kakizaki H,Numasawa K,et al.Preoperative intra-arterial infusion chemotherapy for patients with bladder cancer[J].Eur Urol,1989,16:189-194.
  • 6仇学文,徐汇义,徐卓群,胡强,王志荣,阮钧,诸明.保留膀胱髂内动脉化疗治疗膀胱癌(附38例报告)[J].中华泌尿外科杂志,2001,22(3):154-156. 被引量:14
  • 7[8]Belliveau JF,Posner MR,Ferrari L,et al.Cisplatin administered as a continuous 5-day infusion:plasma platinuous levels and urine platinum excretion[J].Cancer Treat Rep,1986,70:1215-1217.
  • 8[9]Harada T,Ohmura H,Nishizawa O,et al.Efficacy and side effects of the regional arterial infusion of anti-cancer drugs combind with direct hemoperfusion in malignancies of the urinary tract[J].J Urol,1982,128:524.
  • 9[10]Miyanaga N,Ohtani M,Noguchi R,et al.Intra-arterial cisplantin and concurrent radiation for invasive bladder cancer[J].Nippon Hingokika Gakkai Zasshi,1991,82:1583.
  • 10[11]Schulman CC,Wespes E,Delcour C,et al.Intra-arterial chemotherapy of infiltrative bladder carcinoma[J].Eur Urol,1985,11:220.

二级参考文献9

共引文献44

同被引文献18

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部